25/02/2026
I asked ChatGPT a simple systems question:
If Endometriosis had been prioritised from the moment it was first defined — where would care be today?
The answer is uncomfortable.
Endometriosis was described over a century ago.
What followed was not urgency but dismissal, underfunding, and delay.
If Endo/Adeno had received the same research priority as cancer or heart disease, care today would look very different:
• non-invasive diagnostics
• early biomarkers
• disease subtyping
• precision medicine
• pain treated as a primary driver not an afterthought
From a systems-biology perspective, a single “cure” was never the goal.
Because Endometriosis is not one disease.
But long-term remission, stable symptom control, and prevention of progression?
Highly plausible.
The barrier was never biology.
It was priority.
Women’s pain was minimised.
Research stalled.
Suffering continued.
We are not starting from zero —
but we are decades behind where we should be.
The future of Endo/Adeno care lies in:
• immune and pain science
• systems medicine
• personalised, long-term management
Endometriosis doesn’t lack answers.
It lacked attention.
Catching up now requires intelligence, humility and refusing to accept outdated narratives.
[ endometriosis research, endometriosis care gaps, chronic pain science, immune mediated disease, systems biology, women’s health research, evidence based endo care ]